Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management

被引:55
作者
Im, SH [1 ]
Oh, CW [1 ]
Kwon, OK [1 ]
Kim, JE [1 ]
Han, DH [1 ]
机构
[1] Seoul Natl Univ, Dept Neurosurg, Bundang Hosp, Coll Med, Seongnam 463707, Kyeonggi Do, South Korea
关键词
Graves disease; moyamoya disease; hyperthyroidism; cerebral ischemia;
D O I
10.3171/jns.2005.102.6.1013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. In moyamoya disease (MMD), ischemic events are usually precipitated by activities associated with hyperventilation or physical strain. The authors report on four patients with a rare combination of Graves disease-associated thyrotoxicosis and MMD, whose cerebrovascular ischemic events occurred while in a thyrotoxic state. The clinical correlation between MMD and Graves' thyrotoxicosis, and outcome after surgical intervention are described. Methods. Four Young women, ages 22 to 25 years, presented with profound cerebrovascular ischemic accidents. They had clinical and radiological features consistent with the diagnosis of MMD and were in the active thyrotoxic state of Graves disease. To prevent a future ischemic event, patients underwent superficial temporal artery-middle cerebral artery anastomosis combined with encephalornyosynangiosis or encephaloduroarteriosynangiosis after normalization of their hormonal conditions. All patients have been neurologically stable since revascularization procedures and lead a normal daily life. In patients with MMD, cerebrovascular ischemic events may be precipitated by thyrotoxicosis. One possible pathomechanism of cerebrovascular ischemic aggravation in the thyrotoxic state may be a hemodynamic compromise induced by an excessive increase in the cerebral metabolism and oxygen demand over the compensation of the cerebral blood flow deficit through collateral supply in MMD. Conclusions. Surgical revascularization after optimal control of thyrotoxicosis is thought to be an appropriate treatment in patients with MMD concurrent with Graves disease for the prevention of further ischemic events, especially in those with impaired cerebral perfusion and cerebral ischemic symptoms.
引用
收藏
页码:1013 / 1017
页数:5
相关论文
共 16 条
[1]   BRAIN CHEMI-LUMINESCENCE AND OXIDATIVE STRESS IN HYPERTHYROID RATS [J].
ADAMO, AM ;
LLESUY, SF ;
PASQUINI, JM ;
BOVERIS, A .
BIOCHEMICAL JOURNAL, 1989, 263 (01) :273-277
[2]   Cardiac oxidative metabolism, function, and metabolic performance in mild hyperthyroidism:: A noninvasive study using positron emission tomography and magnetic resonance imaging [J].
Bengel, FM ;
Lehnert, J ;
Ibrahim, T ;
Klein, C ;
Bülow, HP ;
Nekolla, SG ;
Schwaiger, M .
THYROID, 2003, 13 (05) :471-477
[3]   Autoimmunity in thyroid disease [J].
Collins, J ;
Gough, S .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (Suppl 2) :S417-S424
[4]   Moyamoya and Down syndrome - Clinical and radiological features [J].
Cramer, SC ;
Robertson, RL ;
Dooling, EC ;
Scott, RM .
STROKE, 1996, 27 (11) :2131-2135
[5]   Current state of study on Moyamoya disease in Japan [J].
Fukui, M .
SURGICAL NEUROLOGY, 1997, 47 (02) :138-143
[6]   RELATIONSHIP BETWEEN THE RESTING METABOLIC-RATE AND HEPATIC-METABOLISM IN RATS - EFFECT OF HYPERTHYROIDISM AND FASTING FOR 24 HOURS [J].
IOSSA, S ;
LIVERINI, G ;
BARLETTA, A .
JOURNAL OF ENDOCRINOLOGY, 1992, 135 (01) :45-51
[7]   Dilated cardiomyopathy in thyrotoxicosis and Moyamoya disease [J].
Kim, JY ;
Kim, BS ;
Kang, JH .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 80 (01) :101-103
[8]   GRAVES THYROTOXICOSIS AND MOYAMOYA DISEASE [J].
KUSHIMA, K ;
SATOH, Y ;
BAN, Y ;
TANIYAMA, M ;
ITO, K ;
SUGITA, K .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1991, 18 (02) :140-142
[9]   Autoimmunity in Down's syndrome: Another possible mechanism of moyamoya disease [J].
Leno, C ;
Mateo, I ;
Cid, C ;
Berciano, J ;
Sedano, C .
STROKE, 1998, 29 (04) :868-869
[10]  
Liu Jia-Shou, 1994, Journal of the Formosan Medical Association, V93, P806